The UK mental health sector is experiencing unprecedented demand, driven by rising prevalence of psychological conditions and growing societal awareness of the importance of mental wellbeing. This surge is straining public systems and fuelling the rapid emergence of tech-enabled outpatient providers, whose scalable, asset-light models are transforming access to care. Private equity interest in the sector has intensified, underpinned by robust demand, policy tailwinds, and the proven ability of digital platforms to deliver cost-effective, accessible solutions at scale. At the same time, corporate employers are significantly increasing their investment in employee well-being, recognising mental health as both a legal and reputational priority. Sir Charlie Mayfield’s 2025 ‘Keep Britain Working’ Report1 underscores the huge economic burden of ill-health in the UK – the reason 1 in 5 working-age adults are now out of the workforce; the report urges employers to partner with the NHS and occupational health providers to improve workplace health provision. These trends create fertile ground for consolidation, as a fragmented landscape of digital and hybrid providers offers opportunities for investors to build platforms with national reach and diversified payor bases.
The opportunity: A convergence of market need and scalable models
Growing societal demand
The macro case for investing in mental health is well established. 1 in 4 people globally will experience a mental or neurological disorder, yet over half of people in high-income countries like the UK and US receive no care2. The cost of untreated mental illness is staggering: the global economic burden is projected to reach $6 trillion by 20303. In the UK, mental ill health is now the leading cause of work-limiting conditions among under-45s4, carrying estimated economic and social costs exceeding £300bn, according to the NHS Confederation Mental Health Network’s 2022 reporting5.
Limited additional funding and in-patient provision is at capacity
Public funding is rising, but demand continues to outstrip supply. Whilst NHS England’s mental health spend has risen from £13.3 billion in 2019/20 to £19.0 billion in 2024/25, this represents only a 0.6 percentage point increase in share of total ICB allocations6 – insufficient to meet surging demand in community-based referrals (up 28.4% in the 24 months to August 20256). Meanwhile, NHS inpatient mental health beds have declined by over 500 since 2019, pushing average occupancy to nearly 90%7 – above the 85% threshold regarded as safe by the Royal College of Psychiatrists.
The digital shift is accelerating
This capacity strain is accelerating outsourcing to the independent sector and, whilst private providers have added ~500 beds since 2019, recent investment has increasingly focused on community and digital services rather than hospitals8. This shift – driven by policy, technology, and patient preference – is creating investable opportunities in outpatient-oriented, scalable businesses.
Together, these dynamics point to a sector characterised by high unmet need and multiple funding routes, suited to scalable, tech-enabled operators capable of relieving pressure on the NHS while capturing sustainable private-pay growth. Whilst digital platforms won’t displace demand for inpatient care in acute cases, they offer complementary growth opportunities – particularly in early intervention and outpatient services. With global investment in digital mental health now exceeding $5 billion annually9, UK policy backing sustained commissioning10, and growing employer demand for mental health support, the sector is poised for continued expansion.
UK market structure – today and tomorrow
FIGURE 1
The payor base for mental health services is diverse and evolving:
• NHS commissioning remains the largest funding channel, particularly through ‘Right to Choose’ and local ICB contracts. Traditionally, commissioning focused on block contracts with large inpatient providers, primarily for high-acuity cases. However, in recent years, this has expanded to include outpatient services such as neurodiversity support – opening the door for a wider range of lower-acuity and digital providers. Scrutiny is intensifying: commissioners are increasingly assessing clinical quality, cost efficiency and governance before renewing contracts, particularly with concerns about inconsistent diagnostic standards. The recent publication of NHS price guidance for ADHD and autism17 is further driving standardisation and price transparency across neurodiversity services.
• Private medical insurers (PMI) such as AXA Health and Bupa fund a growing share of digital mental health assessments and therapy, often preferring providers with multidisciplinary teams and measurable outcomes.
• Corporate employers are expanding spend on digital wellbeing and neurodiversity assessments as workplace mental health becomes a legal and reputational priority.
• Self-pay consumers represent a smaller but rising segment, driven by long NHS waitlists and greater acceptance of digital care
Tech-enabled outpatient providers – such as Onebright, Psychiatry UK, Clinical Partners and ProblemShared – are growing fastest, driven by structural demand and operating model advantages:
• Policy support: NHS contracts for ADHD and talking therapies increasingly favour digital-first providers that can meet wait-time targets at lower cost.
• Scalable, asset-light models: Platforms operate without fixed estates, allowing rapid clinician onboarding and expansion across regions.
• Multidisciplinary teams: Flexible staffing including psychiatrists, psychologists, therapists and nurse prescribers allow providers to manage more patients per pound of spend.
• Changing patient behaviour: COVID-era adoption of telehealth has normalised digital therapy and assessment, lowering non-attendance rates and broadening access to services.
FIGURE 2
Recent transactions: What investors are backing and why
Investor appetite for mental health spans corporate wellbeing, NHS-aligned services, and consumer platforms. Recent deals illustrate a growing interest in models integrating digital tools to deliver services at scale:
TABLE 1
Seed funding of digital mental health platforms and the acquisition of providers offering digital services to the mental health sector have been growing. These deals reflect both the horizontal spread of mental health across corporate and consumer channels, and the vertical shift toward virtual-first care that can triage, diagnose, and monitor at scale.
Many smaller digital mental health providers may be more attractive to growth or small-cap investors. However, larger providers such as Psychiatry UK demonstrate how digital-first models can scale quickly to achieve national reach and significant market share.
Exit optionality remains broad – strategic sales to hospital groups, insurers, occupational health providers or digital health consolidators all remain in play, but only for platforms with proven client retention, sustained engagement, and good clinical outcomes.
Market trends and drivers: From reactive to proactive care
The rise of digital mental health is driven by structural shifts in patient behaviour, care delivery, and funding priorities:
Workplace mental health: The cost to UK employers of poor mental health is rising, increasing by 25% from 2019 to reach ~£55bn in 202111. Public policy is increasingly focused on reducing long-term ‘sickness absence, as outlined in the Government’s ‘Get Britain Working’ and ‘Keep Britain Working’ Reports1, 12. These encourage growing employer investment in platforms (e.g. Latus Health and 7Mind) to support mental wellbeing and reduce absenteeism, with the greatest demand for tailored, measurable solutions that can be integrated with HR strategies. Mental health and wellbeing support is increasingly viewed as an attractive, even essential, perk, with a third of employees indicating they would like to see more support from employers11.
Neurodiversity: Demand for ADHD and autism assessments has surged, with NHS autism referrals rising at ~29% CAGR since 201913. Much of this rapid growth has been enabled by the NHS ‘Right to Choose’ pathway, which allows patients to access independent providers contracting with the NHS for assessments. However, capacity has not kept pace – open (unresolved) referrals have risen at ~60% CAGR13, and waiting lists often exceed two years. Long waits are pushing families toward self-pay, where providers such as Clinical Partners and Onebright are scaling through acquisition and vertical integration. Neurodiversity represents one of the clearest sub-segments where unmet need translates into sustainable private demand.
Policy and public sector contracts: NHS England’s Mental Health Investment Standard mandates real terms spending increases. Commissioners are turning to digital services to plug workforce and capacity gaps, particularly for assessment and triage. The NHS Long Term Plan aims to enhance functionalities of the NHS App, using AI-enabled algorithms, consolidated patient data, and fast access to 24/7 advice. In-app tools will allow patients to make self-referrals to certain mental health services and streamline access to mental health support10.
Consumer tech adoption: COVID-19 catalysed the adoption of telehealth and mental health apps. By April 2020, the top 20 mental wellness apps hit 4 million monthly downloads14. Appetite for accessing help has never been higher: surveys show that 36% of UK working adults used tools to help them manage their mental health in 202111, and over half of 18-24-year-olds would choose a mental health app to support a mental health condition over prescription medication or online therapy15. The uptake of digital health services looks set to continue – mental health apps like Calm and Talkspace now serve millions, with venture funding to match.
Emerging technologies: AI and wearable platforms are beginning to assess and even predict mental health deterioration, with some systems using social media or biometric cues to infer mood or risk in real time2. Hybrid models are emerging, where AI tools triage or monitor symptoms but defer key decisions to clinicians – defining the next phase of digital mental health delivery9.
Hybrid care models: Forward-thinking providers combine digital triage with in-person follow-ups, offering stepped care pathways.
Adjacency overlap: Digital mental health increasingly intersects with occupational health, private medical options (PMO) and insurance (PMI), virtual GP services and EAPs. Providers like Square Health are at the forefront of this convergence, offering integrated solutions that combine mental health support with broader health and wellbeing services to enable holistic care pathways and create new channels for digital mental health. As these boundaries blur, cross-sector partnerships and bundled offerings are set to drive both growth and differentiation in the market.
Risks and ethical dilemmas: Due diligence focus areas
Investors must look beyond growth metrics to assess the long-term sustainability and integrity of digital mental health platforms:
• NHS funding exposure: Recent NHS-driven growth (e.g., due to ADHD assessment backlogs) may not be sustainable, as policy shifts and funding constraints emerge. For example, the temporary pausing of adult ADHD referrals by NHS Coventry and Warwickshire ICB16 and the 2026/27 ADHD and Autism Payment Guidance17 highlight the tightening of long-term public funding. Providers charging above guide prices may face reduced referrals or exclusion from NHS-funded pathways, and future policy iterations could make these prices mandatory. Providers with a diversified payor mix – such as ProblemShared, with revenue from PMI alongside NHS and self-pay funding streams – are best positioned for resilience.
• Clinical effectiveness vs customer stickiness: Platforms should be evaluated on measurable therapeutic outcomes, not just engagement. Experts warn that digital mental health must avoid becoming exploitative or ineffective: ‘sticky’ app designs which mimic social media’s addictive features may boost usage but could be antithetical to therapeutic goals14. As technology advances, balancing innovation with patient safety and ethical standards is paramount. Investors should prioritise platforms that demonstrate both clinical efficacy and responsible use of emerging technologies.
• Evidence and clinical oversight: Evidence-based protocols, validated outcome tracking metrics (e.g. PHQ-9, GAD-7), and clinical oversight are essential. Many D2C apps lack clinical validation, marketing themselves as ‘advice’ rather than medical services to avoid regulatory scrutiny. Investors should beware of regulatory and reputational risks associated with providers chasing engagement at the expense of therapeutic outcomes14. These tools will remain peripheral to acute care, and any intersections will be as consumer-driven add-ons rather than substitutes for medical care.
• Regulatory exposure: Scrutiny is tightening, so companies prioritising growth over compliance may struggle to secure clients if not aligned with NHS and GDPR standards. Furthermore, international scaling requires navigating diverse regulatory and reimbursement dynamics across borders. Success will depend on balancing innovation with integrity – clear clinical safeguards ensuring privacy and optimal patient outcomes will remain key.
• Data governance: AI-driven monitoring (e.g. using social media or biometric activities) raises unresolved questions around data privacy, intervention thresholds, and who is responsible for acting on flagged risks2.
Conclusion: Investing where need meets scale
Digital mental health sits at the intersection of high unmet need, scalable delivery models, and various routes to market – via NHS, corporate, and private payors. Done right, this offers one of the most compelling opportunities in modern healthcare, though successful investors must be selective: backing platforms that deliver measurable clinical benefit, follow ethical frameworks, navigate regulatory complexity, and demonstrate resilience across payor types. As tech-enabled care models continue to evolve, opportunity lies in building trusted providers that can meet demand at scale without compromising care outcomes.
Sources
- Keep Britain Working: Final Report https://www.gov.uk/government/publications/keep-britain-working-review-final-report/keep-britain-working-final-report
- World Economic Forum: Technology could change how we treat mental health, if we can navigate the ethical dilemmas | World Economic Forum
- Quantifying the global burden of mental disorders and their economic value, Arias, Daniel et al., eClinicalMedicine (The Lancet), Volume 54
- https://www.health.org.uk/reports-and-analysis/analysis/what-we-know-about-the-uk-s-working-age-health-challenge
- https://www.centreformentalhealth.org.uk/news/item/investment-in-mental-health-key-to-meeting-key-government-ambitions-says-centre-for-mental-health-report-with-nhs-confederation
- NHS England Mental Health Dashboard
- NHS England
- https://www.kingsfund.org.uk/insight-and-analysis/long-reads/mental-health-360-funding-costs
- The surge in digital mental health solutions
- NHS Long Term Plan 2025
- 2021 Deloitte survey of 3,599 individuals: https://www.deloitte.com/uk/en/services/consulting/analysis/mental-health-and-employers-the-case-for-investment.html
- Get Britain Working White Paper – GOV.UK
- New autism referrals rose from 3,237 (01.04.2019) to 10,831 (01.01.2024); open autism referrals rose from 18,519 (01.04.2019) to 177,012 (01.01.2024) https://app.powerbi.com/view?r=eyJrIjoiMjE0ZGM0MTAtMWU3NS00N2I5LTlhMDAtNzZhNGFlOWYwNzY3IiwidCI6IjM3YzM1NGIyLTg1YjAtNDdmNS1iMjIyLTA3YjQ4ZDc3NGVlMyJ9
- If technology causes mental health issues, can it also be a therapy? | STAT
- ORCHA’s 2022 consumer research: https://orchahealth.com/to-b2c-or-not-to-b2c-the-evolving-digital-health-market/
- https://www.covwarkpt.nhs.uk/latest-news/coventry-and-warwickshire-integrated-care-board-adhd-commissioning-decision-4029/
- Attention-Deficit/Hyperactivity Disorder (ADHD) & Autism Payment Guidance
